AU Patent

AU2012275841A1 — Methods and compositions for treatment of cancer and autoimmune disease

Assigned to Jackson Laboratory · Expires 2014-01-16 · 12y expired

What this patent protects

The technology described herein relates to methods of inducing cell death. The technology described herein further relates to treating conditions including cancers and autoimmune diseases comprising administering inhibitors of double strand break repair. Also described herein are…

USPTO Abstract

The technology described herein relates to methods of inducing cell death. The technology described herein further relates to treating conditions including cancers and autoimmune diseases comprising administering inhibitors of double strand break repair. Also described herein are inhibitors of double strand break repair and methods of screening for such inhibitors.

Drugs covered by this patent

Patent Metadata

Patent number
AU2012275841A1
Jurisdiction
AU
Classification
—
Expires
2014-01-16
Drug substance claim
No
Drug product claim
No
Assignee
Jackson Laboratory
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.